NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Triumeq is a first line treatment containing which of the following?

Dolutegravir/abacavir/lamivudine
Elvitegravir/cobibistat/emtricitabine/TAF
Efavirenz/emtricitabine/TDF
Dolutegravir/lamivudine

The correct answer is: Dolutegravir/abacavir/lamivudine

Triumeq is a first line treatment for HIV that contains a combination of three drugs dolutegravir, an integrase inhibitor; abacavir, a nucleoside reverse transcriptase inhibitor; and lamivudine, another nucleoside reverse transcriptase inhibitor. Option A is the only choice that includes all three of these medications. Option B contains four drugs, including Tenofovir Alafenamide (TAF), which is not one of the ingredients in Triumeq. Option C contains Efavirenz, a non-nucleoside reverse transcriptase inhibitor, and Tenofovir Disoproxil Fumarate (TDF), which is also not included in Triumeq. Option D only has two of the three required medications (dolutegravir and lamivudine), making it an incomplete answer. Therefore, option A is the correct choice as it contains all three components of Triumeq, making it a true first line treatment option.